Margaret A. Liu, MD, DSchc, MDhc, CEO

Margaret is a Harvard Medical School graduate and a world-renowned expert in the fields of gene delivery, vaccines and immunotherapy. She has been a Director, then Advisory Council member, of the American Society for Gene and Cell Therapy, Vice-President of Vaccines and Gene Therapy at Chiron, Senior Advisor for the Bill & Melinda Gates Foundation, and board member at Transgene, Sangamo, Ipsen, and MacroGenics, among other executive, board, and SAB positions. Margaret is Hedersdoktor (Honorary Doctor) with Scientific Affiliation at the Karolinska Institutet in Stockholm, and Adjunct Full Professor at the University of California, San Francisco.

Xiao Tian Wang, MD, Co-founder & Chief Scientific Officer

Xiao is a Research Assistant Professor at Brown University and has been involved in gene therapy research with Dr. Paul Liu for 20 years. She developed the AAV2-VEGF vector, and the work (this project) won the 3M Award of Excellence in Translational Regenerative Science at a Wound Healing Society Annual Meeting.

Sanjay Gokhale, MBA, VP of Corporate Development & CFO

Sanjay has more than three decades of experience in Investment Banking, Venture Capital, Corporate Development and Entrepreneurship. He has been involved in M&A advisory assignments, as well as financing and licensing transactions valued in excess of $10 billion. Sanjay holds a Bachelor of Chemical Engineering degree from the Institute of Chemical Technology in India, and an MBA from Rice University in Houston, Texas.

​

Robert G. Johnson, MD, PhD, Chief Business Development Officer

Robert received his MD and PhD from UPenn, and has served on the medical faculties of Harvard Medical School and UPenn as a Howard Hughes Medical Institute Investigator. He was CEO of KOSAN Pharmaceuticals, and COO for GenVivo, Inc. developing gene therapy cancer therapeutics and managing their research, clinical trials, manufacturing, and intellectual property.

​

Karl H. Breuing, MD, FACS, Surgical Clinical Advisor

Karl is Professor of Surgery at The Warren Alpert Medical School of Brown University and a board-certified plastic and reconstructive surgeon with internationally recognized expertise in regenerative medicine, wound healing, and reconstructive surgery. Over a distinguished career spanning more than four decades, he has advanced the clinical application of biomaterials and tissue regeneration while serving as an educator, researcher, and advisor to the medical device and biotechnology industries.

​

Manuel F. DaSilva, MD, FAAOS, Surgical Clinical Advisor

Manuel is a Professor of Orthopedics at the Warren Alpert Medical School of Brown University. He specializes in the treatment of injuries and musculoskeletal conditions related to the hand, wrist, elbow, and shoulder having completed advanced training in orthopedic trauma, and hand, wrist, elbow, shoulder, and micro-vascular surgery. He has pioneered elbow arthroscopy techniques for the treatment of elbow pathologies, as well as arthroscopic techniques for the small joints of the hand and wrist. He in an inventor and innovator holding multiple patents related to surgical instrumentation.

  ​

Joseph C. Benacci, MD, FACS, Surgical Clinical Advisor

Joe is a graduate of the University of Pennsylvania School of Medicine.  He trained in General Surgery at the Mayo Clinic in Minnesota, did his Plastic Surgery at the Lahey Clinic in Massachusetts and did a Reconstructive Microsurgery Fellowship at the MD Anderson Cancer Center in Texas.  Joe is a Plastic Surgeon at the Emplify - Gundersen Health System in Wisconsin where he formerly served as Chairman in Plastic Surgery for 16 years.​

​

Richard Junghans, MD, PhD, Advisor for Clinical Trials

Dick earned his PhD in Immunology from UC Berkeley, followed by a Post-doc at CalTech, then attended medical school at U Miami. He has patented and developed armed targeted T-cell therapies for several cancers, and has completed multiple gene therapy clinical trials that afford him unique insight into FDA requirements and reporting. He is a practicing oncologist and President of IT BIO, LLC.

Jin Bo Tang, MD, Surgical Advisor for Tendons and Ligaments

Dr. Jin Bo Tang is Secretary-General of International Federation for Societies of Surgery of the Hand (IFSSH) and will be president 2031-2034. He is Editor-in-Chief of the acclaimed new hand surgery text book Current Practice in Hand Surgery, published by Elsevier in 2025. This is the first comprehensive textbook supported by IFSSH for the worldwide hand surgery community. 

​

In memoriam Paul Liu, MD, MA, MA ad eundem, Co-Founder

Paul was Chair and Professor of Plastic Surgery at Brown University. He was educated at Harvard Medical School and Oxford University, where he was a Marshall Scholar. Paul was trained in general surgery and plastics at the Brigham / Children’s / Harvard. He is Past President of the Wound Healing Society, and led a clinical department of 10 surgeons and 40 employees with revenues of ~$25 million/year.